Veracyte

(NASDAQ) VCYT

Current Price$38.92

Market Cap$3.05B

Since IPO (2013)+189%

5 Year+5%

1 Year+31%

1 Month+18%

Veracyte Financials at a Glance

Market Cap

$3.05B

Revenue (TTM)

$541.74M

Net Income (TTM)

$88.01M

EPS (TTM)

$1.09

P/E Ratio

35.21

Dividend

$0.00

Beta (Volatility)

1.91 (High)

Dividend

$0.00

Beta (Volatility)

1.91 (High)

Price

$38.92

Volume

558,104.041

Open

$38.88

Price

$38.92

Volume

558,104.041

Open

$38.88

Previous Close

$38.25

Daily Range

$38.05 - $39.66

52-Week Range

$22.61 - $50.71

Dividend

$0.00

Beta (Volatility)

1.91 (High)

Price

$38.92

Volume

558,104.041

Open

$38.88

Previous Close

$38.25

Daily Range

$38.05 - $39.66

52-Week Range

$22.61 - $50.71

VCYT News

Here's Why This Little-Known Growth Stock Is a Buy

Kody KesterMay 22, 2023

Double-Digit Sales Growth: Is This Stock a Convincing Buy for Growth Investors?

Kody KesterMar 10, 2023

Better Long-Term Buy in 2023: Exact Sciences or Veracyte?

James HalleyJan 24, 2023

A patient at an appointment with their doctor

This Small-Cap Stock Is a No-Brainer Buy

Kody KesterJan 18, 2023

A doctor and patient discuss test results at an appointment

Should Growth Investors Buy This Little-Known Stock?

Kody KesterSep 24, 2022

Page 1

VCYT: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Veracyte

Industry

Biotechnology

Sector

Health Care

Employees

755

CEO

Marc A. Stapley

Website

www.veracyte.com

Headquarters

South San Francisco, CA 94080, US

VCYT Financials

Key Financial Metrics (TTM)

Gross Margin

71%

Operating Margin

12%

Net Income Margin

16%

Return on Equity

Return on Capital

Return on Assets

Earnings Yield

2.84%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$3.05B

Shares Outstanding

79.79M

Volume

558.10K

Avg. Volume

946.06K

Financials (TTM)

Gross Profit

$360.05M

Operating Income

$74.15M

EBITDA

$89.62M

Operating Cash Flow

$136.31M

Capital Expenditure

$9.68M

Free Cash Flow

$126.63M

Cash & ST Invst.

$412.89M

Total Debt

$39.65M

Veracyte Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$139.07M

+21.5%

Gross Profit

$100.58M

+26.5%

Gross Margin

72.32%

N/A

Market Cap

$3.05B

N/A

Market Cap/Employee

$3.70M

N/A

Employees

824

N/A

Net Income

$28.71M

+307.4%

EBITDA

$29.28M

+348.6%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$399.73M

+68.8%

Accounts Receivable

$50.11M

-6.8%

Inventory

$0.00

-100.0%

Long Term Debt

$34.99M

-18.8%

Short Term Debt

$4.35M

-41.3%

Return on Assets

6.13%

N/A

Return on Invested Capital

4.89%

N/A

Free Cash Flow

$32.25M

+810.3%

Operating Cash Flow

$35.22M

+556.8%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

TARSTarsus Pharmaceuticals, Inc.

TARSTarsus Pharmaceuticals, Inc.$65.00+0.53%

IRONDisc Medicine, Inc.

IRONDisc Medicine, Inc.$69.64-0.56%

IDYAIDEAYA Biosciences, Inc.

IDYAIDEAYA Biosciences, Inc.$28.87-0.10%

ZLABZai Lab Limited

ZLABZai Lab Limited$20.35-0.59%

ADPTAdaptive Biotechnologies Corporation

ADPTAdaptive Biotechnologies Corporation$13.18+0.34%

KNSAKiniksa Pharmaceuticals, Ltd.

KNSAKiniksa Pharmaceuticals, Ltd.$58.84-0.47%

FOLDAmicus Therapeutics, Inc.

FOLDAmicus Therapeutics, Inc.$14.49+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

AIIORobo.ai

AIIORobo.ai$6.68+1.56%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$16.82-0.00%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$79.15+0.02%

AALAmerican Airlines Group

AALAmerican Airlines Group$12.68-0.00%

IRENIren

IRENIren$58.19+0.05%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$40.97-0.02%

EOSEEos Energy Enterprises

EOSEEos Energy Enterprises$8.13-0.02%

Questions About VCYT

What is the current price of Veracyte?

Veracyte is trading at $38.94 per share.

What is the 52-week range for Veracyte?

Over the past 52 weeks, Veracyte has traded between $22.61 and $50.71.

How much debt does Veracyte have?

As of the most recent reporting period, Veracyte reported total debt of $39.33M.

How much cash does Veracyte have on hand?

Veracyte reported $263.14M in cash and cash equivalents in its most recent financial results.

What is Veracyte’s dividend yield?

Veracyte does not currently have a dividend yield.

Veracyte

Veracyte Financials at a Glance

VCYT News

Why Veracyte Stock Is Skyrocketing Higher This Week

Veracyte (VCYT) Q2 Revenue Jumps 14%

Is This Underfollowed Genetic Diagnostics Stock a Buy for Growth Investors?

Here's Why This Little-Known Growth Stock Is a Buy

Double-Digit Sales Growth: Is This Stock a Convincing Buy for Growth Investors?

Better Long-Term Buy in 2023: Exact Sciences or Veracyte?

This Small-Cap Stock Is a No-Brainer Buy

Should Growth Investors Buy This Little-Known Stock?

VCYT: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Veracyte

VCYT Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Veracyte Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About VCYT

What is the current price of Veracyte?

What is the 52-week range for Veracyte?

How much debt does Veracyte have?

How much cash does Veracyte have on hand?

What is Veracyte’s dividend yield?

Premium Investing Services